Morgan Marks, PhD

Moderna, Inc.

Poster(s):

• (341) Early use of Moderna’s mRNA-1273.815 monovalent vaccine: a descriptive analysis of a US Claims database
  Wednesday, August 28, 2024

  8:00 AM – 1:30 PM CEST

• (ASPOT02) Contents of a Strong Real World Data Quality and Relevance Package for Regulatory or Health Technology Assessment Submission
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST